Maeda, H.; Miura, K.; Aizawa, K.; Bat-Erdene, O.; Sashikawa-Kimura, M.; Noguchi, E.; Watanabe, M.; Yamada, N.; Osaka, H.; Morimoto, N.;
et al. Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants 2024, 13, 805.
https://doi.org/10.3390/antiox13070805
AMA Style
Maeda H, Miura K, Aizawa K, Bat-Erdene O, Sashikawa-Kimura M, Noguchi E, Watanabe M, Yamada N, Osaka H, Morimoto N,
et al. Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants. 2024; 13(7):805.
https://doi.org/10.3390/antiox13070805
Chicago/Turabian Style
Maeda, Hiroshi, Kouichi Miura, Kenichi Aizawa, Oyunjargal Bat-Erdene, Miho Sashikawa-Kimura, Eri Noguchi, Masako Watanabe, Naoya Yamada, Hitoshi Osaka, Naoki Morimoto,
and et al. 2024. "Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis" Antioxidants 13, no. 7: 805.
https://doi.org/10.3390/antiox13070805
APA Style
Maeda, H., Miura, K., Aizawa, K., Bat-Erdene, O., Sashikawa-Kimura, M., Noguchi, E., Watanabe, M., Yamada, N., Osaka, H., Morimoto, N., & Yamamoto, H.
(2024). Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants, 13(7), 805.
https://doi.org/10.3390/antiox13070805